Kidswell Bio Corporation (4584.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenJPY 162.00

From 52W high−47.02%

Volume245500.00

Market capJPY 7.94B

P/E (TTM)185.5x

P/S (TTM)1.3x

Div yield—

Key dataSep 18, 2026

Open

JPY 162.00

From 52W high

−47.02%

Volume

245500.00

Market cap

JPY 7.94B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−33.0x

P/E (TTM)

185.5x

RSI (14)

49.1

MomentumView details →

1D Return

+0.00%

YTD Return

−19.70%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

185.5x

EV/EBITDA

−33.0x

EV/Sales

1.2x

P/S (TTM)

1.3x

P/B (TTM)

4.3x

ProfitabilityView details →

Gross Margin

23.22%

Net Margin

0.34%

EBITDA Margin

0.39%

ROE (TTM)

1.25%

ROA (TTM)

0.38%

Asset Turnover

1.16x

GrowthView details →

Revenue YoY

+81.08%

EPS YoY

+105.13%

FCF YoY

—

Revenue CAGR 3Y

+47.96%

EPS CAGR 3Y

+98.71%

EBITDA YoY

—

MomentumView details →

1D Return

+0.00%

YTD Return

−19.70%

1Y Return

−40.51%

RSI (14)

49.1

vs 50D SMA

+3.19%

vs 200D SMA

−20.02%

Capital & dividendView details →

Debt/Equity

1.30x

Current Ratio

3.07x

Quick Ratio

2.76x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

7.06B

Net Income (TTM)

24.00M

Op. CF (TTM)

—

Next earningsNov 11, 2026 →

Latest newsMore news →

Kids Well Bio announced that its subsidiary S-Quatre, in collaboration with Nagoya University, completed a clinical study on cerebral palsy treatment using stem cells derived from baby teeth, with an independent safety evaluation committee confirming safety throughout the observation period.38d ago

Kids Well Bio announced its first-quarter results for April-June 2026, with consolidated ordinary profit rising 16.0% year-on-year to 200 million yen.39d ago

Similar companies

OncoTherapy Science,Inc.4564.T Carna Biosciences,Inc.4572.T Nano Holdings,Inc.4571.T J-Pharma Co.,Ltd.520A.T Solasia Pharma K.K.4597.T MORISHITA JINTAN CO.,LTD.4524.T Find similar companies →

Latest newsMore news →

Kids Well Bio announced that its subsidiary S-Quatre, in collaboration with Nagoya University, completed a clinical study on cerebral palsy treatment using stem cells derived from baby teeth, with an independent safety evaluation committee confirming safety throughout the observation period.38d ago Kids Well Bio announced its first-quarter results for April-June 2026, with consolidated ordinary profit rising 16.0% year-on-year to 200 million yen.39d ago